Jenoptik AG (XTRA:JEN) agreed to acquire BG Medical Applications GmbH, SwissOptic AG and SwissOptic (Wuhan) Co., Ltd. from Berliner Glas KGaA Herbert Kubatz GmbH & Co. for ?300 million on October 19, 2021. The acquisition will be financed with existing cash on hand and undrawn credit lines. The management will continue to act in its current function for Berliner Glas Medical and SwissOptic under the umbrella of the Jenoptik Group. The JENOPTIK AG Supervisory Board is supporting the acquisition and has already approved the transaction and is still subject to the approval from the German Federal Cartel Office (Bundeskartellamt) and regulatory approval. Closing is expected for December 2021. In 2022, the acquired companies are expected to contribute approximately ?130 million in revenue. Even after completion of the acquisition, Jenoptik will continue to have a very healthy balance sheet and a sound financial position. The transaction will already have a positive effect on Jenoptik?s business performance in 2022. BofA Securities, Inc. acted as financial advisor to ASML Holding N.V. parent of Berliner Glas KGaA Herbert Kubatz GmbH & Co. Team led by Carola Glasauer including Lutz Kr?mer, Tim Bracksiek, Sebastian St?tze, Thilo Wienke, Lars Petersen and Andreas van den Eikel of White & Case LLP and Urs P. Gnos and?Hans Rudolf Tr?eb of Walder Wyss Ltd. acted as legal advisor to Jenoptik AG. Ulrike Glueck of CMS von Erlach Poncet of CMS von Erlach Poncet acted as legal advisor to Jenoptik AG (XTRA:JEN).